Reportlinker Adds Orthobiologics to 2016 - Alternatives to Surgery and Superior Outcomes are Driving Wider Adoption of Orthobiologics

Mar 29, 2011, 07:36 ET from Reportlinker

NEW YORK, March 29, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Orthobiologics to 2016 - Alternatives to Surgery and Superior Outcomes are Driving Wider Adoption of Orthobiologics

http://www.reportlinker.com/p0464106/Orthobiologics-to-2016---Alternatives-to-Surgery-and-Superior-Outcomes-are-Driving-Wider-Adoption-of-Orthobiologics.html

Orthobiologics to 2016 - Alternatives to Surgery and Superior Outcomes are Driving Wider Adoption of Orthobiologics

Summary

GBI Research's new report, "Orthobiologics to 2016 - Alternatives to Surgery and Superior Outcomes are Driving Wider Adoption of Orthobiologics" provides key data, information and analysis on the Orthobiologics industry and analytical content on the market dynamics. The report provides market landscape, competitive landscape and market trends information on Orthobiologics industry . The report provides comprehensive information on the current practices and trends in the Orthobiologics industry. The report also reviews the competitive landscape, and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

Scope

- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.

- Market size and company share data for Orthobiologics.

- Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2009..

- Qualitative analysis of key market trends, market drivers, and restraints by each category within the Orthobiologics market.

- The report also covers information on the leading market players, the competitive landscape, and the leading technologies.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the Orthobilogics market globally.

- Design and develop your product development, marketing and sales strategies.

- Exploit M&A opportunities by identifying market players with the most innovative pipeline.

- Develop market-entry and market expansion strategies.

- Identify key players best positioned to take advantage of the emerging market opportunities.

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.

- What's the next being thing in the Orthobilogics market? – Identify, understand and capitalize.

- Make more informed business decisions from the insightful and in-depth analysis of the global Orthobilogics market and the factors shaping it.

Table of Contents

1 Table of Contents

1 Table of Contents 4

1.1 List of Tables 7

1.2 List of Figures 8

2 Introduction 9

2.1 GBI Research Guidance 9

3 Overview: Orthobiologics 10

3.1 Applications of Orthobiologics 10

4 Global Orthobiologics Devices : Market Characterization 12

4.1 Global Orthobiologics Devices Market, Revenue ($bn), 2002 – 2009 12

4.2 Global Orthobiologics Devices Market, Revenue Forecast ($bn), 2009–2016 13

4.3 Global Orthobiologics Devices Market, Key Company Shares (%), 2009 14

4.4 Global Orthobiologics Devices Market, Dynamics 16

4.4.1 Market Drivers 16

4.4.2 Market Restraints 18

5 Global Orthobiologics Devices Market: Category Analysis and Forecasts 19

5.1 Global Bone Graft Substitutes Market, Revenue ($m), Historic, 2002 – 2009 19

5.2 Global Bone Graft Substitutes Market, Revenue ($m), Forecast, 2009 – 2016 20

5.2.1 Bone Graft Substitutes, Market Drivers 21

5.2.2 Bone Graft Substitutes, Market Restraint: Safety Concerns over Bone Morphogenetic Protein (BMP) in Spinal Fusion Surgeries and High Cost is Slowing the Adoption 21

5.3 Global Viscosupplementation Market, Revenue ($m), Historic, 2002 – 2009 22

5.4 Global Viscosupplementation Market, Revenue ($m), Forecast, 2009 – 2016 23

5.4.1 Viscosupplementation, Market Drivers 24

5.4.2 Viscosupplementation, Market Restraint: Pricing Challenges to Continue to Plague the Viscosupplementation Market 24

5.5 Global DBM Market, Revenue ($m), Historic, 2002 – 2009 25

5.6 Global DBM Market, Revenue ($m), Forecast, 2009 – 2016 26

5.6.1 DBM, Market Drivers 27

5.6.2 DBM, Market Restraint: Several Potential Disadvantages Such as the Potential to Transmit Human Immunodeficiency Virus May Act as a Restraint on Market Growth 27

5.7 Global Bone Growth Stimulators Market, Revenues ($m), Historic, 2002 – 2009 28

5.8 Global Bone Growth Stimulators Market, Revenues ($m), Forecast, 2009 – 2016 29

5.8.1 Bone Growth Stimulators, Market Driver: Increasing Number of Fractures due to Ageing is Expected to Drive the Market Growth for Bone Growth Stimulators 30

5.8.2 Bone Growth Stimulators, Market Restraint: Lack of Exact Knowledge about the Mechanism of Action for These Devices and Lack of Studies in Specific Patient Groups will Restrict their Adoption 30

5.9 Global Bone Allografts Market, Revenue ($m), Historic, 2002-2009 31

5.10 Global Bone Allografts Market, Revenue ($m), Forecast, 2009-2016 32

6 Global Orthobiologics Devices Market: Country Analysis and Forecasts 33

6.1 Historic (2002–2009) and Forecast (2009-2016) Revenue, By Country 33

6.1.1 Orthobiologics Devices Market, US, Revenue ($bn), 2002 – 2009 33

6.1.2 Orthobiologics Devices Market, Canada, Revenue ($m), 2002–2009 35

6.1.3 Orthobiologics Devices Market, Canada, Revenue ($m), 2009–2016 36

6.1.4 Orthobiologics Devices Market, UK, Revenue ($m), 2002–2009 37

6.1.5 Orthobiologics Devices Market, UK, Revenue ($m), 2009–2016 38

6.1.6 Orthobiologics Devices Market, Germany, Revenue ($m), 2002 – 2009 39

6.1.7 Orthobiologics Devices Market, Germany, Revenue ($m), 2009–2016 40

6.1.8 Orthobiologics Devices Market, France, Revenue ($m), 2002–2009 41

6.1.9 Orthobiologics Devices Market, France, Revenue ($m), 2009–2016 42

6.1.10 Orthobiologics Devices Market, Italy, Revenue ($m), 2002–2009 43

6.1.11 Orthobiologics Devices Market, Italy, Revenue ($m), 2009–2016 44

6.1.12 Orthobiologics Devices Market, Spain, Revenue ($m), 2002–2009 45

6.1.13 Orthobiologics Devices Market, Spain, Revenue ($m), 2009–2016 46

6.1.14 Orthobiologics Devices Market, Brazil, Revenue ($m), 2002–2009 47

6.1.15 Orthobiologics Devices Market, Brazil, Revenue ($m), 2009–2016 48

6.1.16 Orthobiologics Devices Market, Japan, Revenue ($m), 2002–2009 49

6.1.17 Orthobiologics Devices Market, Japan, Revenue ($m), 2009–2016 50

6.1.18 Orthobiologics Devices Market, China, Revenue ($m), 2002–2009 51

6.1.19 Orthobiologics Devices Market, China, Revenue ($m), 2009–2016 52

6.1.20 Orthobiologics Devices Market, India, Revenue ($m), 2002–2009 53

6.1.21 Orthobiologics Devices Market, India, Revenue ($m), 2009–2016 54

6.1.22 Orthobiologics Devices Market, Australia, Revenue ($m), 2002–2009 55

6.1.23 Orthobiologics Devices Market, Australia, Revenue ($m), 2009–2016 56

7 Global Orthobiologics Devices Market: Competitive Assessment 57

7.1 Medtronic Inc. 57

7.1.1 Overview: 57

7.2 Genzyme Corporation 58

7.2.1 Overview 58

7.3 Depuy, Inc.(Johnson & Johnson) 58

7.3.1 Overview 58

7.4 Synthes, Inc. 59

7.4.1 Overview 59

7.5 Smith & Nephew Plc 60

7.5.1 Overview 60

7.6 Stryker 61

7.6.1 Overview 61

7.7 Orthofix International N.V 62

7.7.1 Overview 62

8 Global Orthobiologics Devices Market: Product Pipeline Analysis 63

8.1 Orthobiologics Market: Pipeline Products Summary 63

8.2 Profiles of Promising Products Under Clinical Development: 65

8.2.1 Synthetic Bone Graft Substitutes 65

8.2.2 BMP 67

8.2.3 Bone Growth Stimulators 68

8.2.4 Bone Allograft 70

8.2.5 Viscosupplementation 70

8.2.6 DBM 71

8.3 List of Pipeline Products 71

8.3.1 Pipeline Product Summary 71

9 Global Orthobiologics Devices Market: Consolidation Landscape 75

9.1 Key Deals 78

9.1.1 Medtronic to Acquire Osteotech 78

9.1.2 Landec Acquires Lifecore Biomedical 78

9.1.3 Baxter International Completes Acquisition Of ApaTech 79

9.1.4 TiGenix Completes Acquisition Of OrthoMimetics 79

9.1.5 NuVasive Invests In Progentix Orthobiology 79

9.1.6 Kinetic Concepts Acquires LifeCell 80

9.1.7 Pioneer Surgical Acquires Angstrom Medica 80

9.1.8 Pioneer Surgical Technology Acquires Encelle 80

9.1.9 Orthofix Acquires Blackstone Medical 80

10 Appendix 81

10.1 Definitions 81

10.1.1 Orthobiologics 81

10.2 Acronyms 81

10.3 Sources 82

10.4 Research Methodology 82

10.4.1 Secondary Research 82

10.4.2 Primary Research 82

10.4.3 Models 83

10.4.4 Forecasts 83

10.4.5 Expert Panels 83

10.5 Contact Us 83

10.6 Disclaimer 84

List of Tables

1.1 List of Tables

Table 1: Global Orthobiologics Devices Market, Revenue ($bn), 2002 - 2009 12

Table 2: Global Orthobiologics Devices Market, Revenue Forecast ($bn), 2009 - 2016 13

Table 3: Global Orthobiologics Devices Market, Key Company Share (Revenue $m), 2009 15

Table 4: Global Bone Graft Substitutes Market, Revenue ($m), Historic 2002 - 2009 19

Table 5: Global Bone Graft Substitutes Market, Revenue ($m), Forecast 2009 - 2016 20

Table 6: Global Viscosupplementation Market Revenue ($m), Historic, 2002 - 2009 22

Table 7: Global Viscosupplementation Market, Revenue ($m), Forecast, 2009 - 2016 23

Table 8: Global DBM Market, Revenue ($m), Historic, 2002 - 2009 25

Table 9: Global DBM Market, Revenue ($m), Forecast, 2009 - 2016 26

Table 10: Global Bone Growth Stimulators Market, Revenue ($m), Historic , 2002 - 2009 28

Table 11: Global Bone Growth Stimulators Market, Revenues ($m), Forecast 2009 - 2016 29

Table 12: Global Bone Allografts Market, Revenue ($m), Historic, 2002 - 2009 31

Table 13: Global Bone Allografts Market, Revenue ($m), Forecast, 2009 - 2016 32

Table 14: Orthobiologics Market, US, Revenue ($m), 2002-2009 33

Table 15: Orthobiologics Market, US, Revenue ($m), 2009-2016 34

Table 16: Orthobiologics Market, Canada, Revenue ($m), 2002-2009 35

Table 17: Orthobiologics Market, Canada, Revenue ($m), 2009-2016 36

Table 18: Orthobiologics Market, UK, Revenue ($m), 2002-2009 37

Table 19: Orthobiologics Market, UK, Revenue ($m), 2009-2016 38

Table 20: Orthobiologics Market, Germany, Revenue ($m), 2002-2009 39

Table 21: Orthobiologics Market, Germany, Revenue ($m), 2009-2016 40

Table 22: Orthobiologics Market, France, Revenue ($m), 2002-2009 41

Table 23: Orthobiologics Market, France, Revenue ($m), 2009-2016 42

Table 24: Orthobiologics Market, Italy, Revenue ($m), 2002-2009 43

Table 25: Orthobiologics Market, Italy, Revenue ($m), 2009-2016 44

Table 26: Orthobiologics Market, Spain, Revenue ($m), 2002-2009 45

Table 27: Orthobiologics Market, Spain, Revenue ($m), 2009-2016 46

Table 28: Orthobiologics Market, Brazil, Revenue ($m), 2002-2009 47

Table 29: Orthobiologics Market, Brazil, Revenue ($m), 2009-2016 48

Table 30: Orthobiologics Market, Japan, Revenue ($m), 2002-2009 49

Table 31: Orthobiologics Market, Japan, Revenue ($m), 2009-2016 50

Table 32: Orthobiologics Market, China, Revenue ($m), 2002-2009 51

Table 33: Orthobiologics Market, China, Revenue ($m), 2009-2016 52

Table 34: Orthobiologics Market, India, Revenue ($m), 2002-2009 53

Table 35: Orthobiologics Market, India, Revenue ($m), 2009-2016 54

Table 36: Orthobiologics Market, Australia, Revenue ($m), 2002-2009 55

Table 37: Orthobiologics Market, Australia, Revenue ($m), 2009-2016 56

Table 38: Medtronic, Inc. , Marketed Products, 2010 57

Table 39: Genzyme Corporation, Marketed Products, 2010 58

Table 40: Depuy, Marketed Products, 2010 58

Table 41: Synthes, Inc, Marketed Products, 2010 59

Table 42: Smith & Nephew, Marketed Products, 2010 60

Table 43: Stryker, Marketed Products, 2010 61

Table 44: Orthofix International, Marketed Products, 2010 62

Table 45: Pipeline Products, Orthobiologics, by Development Stage, Global, 2010 63

Table 46: Pipeline Products, Orthobiologics, by Segment, Global, 2010 64

Table 47: To Evaluate The Safety And Effectiveness Of GEM OS1 Compared To Autologous Bone Graft As A Bone Regeneration Device In Foot And Ankle Fusions 65

Table 48: The Efficacy Of rhBMP-2 For Posterolateral Lumbar Fusion In Smokers 67

Table 49: Orthobiologics, Pipeline Products, BMP, 2010 71

Table 50: Orthobiologics, Pipeline Products, Bone Allografts, 2010 72

Table 51: Orthobiologics, Pipeline Products, Bone Graft Substitutes, 2010 72

Table 52: Orthobiologics, Pipeline Products, Bone Growth Stimulators, 2010 73

Table 53: Orthobiologics, Pipeline Products, DBM, 2010 73

Table 54: Orthobiologics, Pipeline Products, Viscosupplementation, 2010 74

Table 55: Orthobiologics Market, Key Deals, 2006–2010* 76

List of Figures

1.2 List of Figures

Figure 1: Global Orthobiologics Devices Market, Revenue ($bn), 2002 - 2009 12

Figure 2: Global Orthobiologics Devices Market, Revenue Forecast ($bn), 2009 - 2016 13

Figure 3: Global Orthobiologics Devices Market, Key Company Shares (%), 2009 14

Figure 4: Global Bone Graft Substitutes Market, Revenue ($m), Historic 2002 - 2009 19

Figure 5: Global Bone Graft Substitutes Market, Revenue ($m), Forecast 2009 - 2016 20

Figure 6: Global Viscosupplementation Market Revenue ($m), Historic, 2002 - 2009 22

Figure 7: Global Viscosupplementation Market, Revenue ($m), Forecast, 2009 - 2016 23

Figure 8: Global DBM Market, Revenue ($m), Historic, 2002 - 2009 25

Figure 9: Global DBM Market, Revenue ($m), Forecast, 2009 - 2016 26

Figure 10: Global Bone Growth Stimulators Market, Revenue ($m), Historic , 2002 - 2009 28

Figure 11: Global Bone Growth Stimulators Market, Revenues ($m), Forecast 2009 - 2016 29

Figure 12: Global Bone Allografts Market, Revenue ($m), Historic, 2002 - 2009 31

Figure 13: Global Bone Allografts Market, Revenue ($m), Forecast, 2009 - 2016 32

Figure 15: Orthobiologics Market, US, Revenue ($m), 2002-2009 33

Figure 16: Orthobiologics Market, US, Revenue ($m), 2009-2016 34

Figure 17: Orthobiologics Market, Canada, Revenue ($m), 2002-2009 35

Figure 18: Orthobiologics Market, Canada, Revenue ($m), 2009-2016 36

Figure 19: Orthobiologics Market, UK, Revenue ($m), 2002-2009 37

Figure 20: Orthobiologics Market, UK, Revenue ($m), 2009-2016 38

Figure 21: Orthobiologics Market, Germany, Revenue ($m), 2002-2009 39

Figure 22: Orthobiologics Market, Germany, Revenue ($m), 2009-2016 40

Figure 23: Orthobiologics Market, France, Revenue ($m), 2002-2009 41

Figure 24: Orthobiologics Market, France, Revenue ($m), 2009-2016 42

Figure 25: Orthobiologics Market, Italy, Revenue ($m), 2002-2009 43

Figure 26: Orthobiologics Market, Italy, Revenue ($m), 2009-2016 44

Figure 27: Orthobiologics Market, Spain, Revenue ($m), 2002-2009 45

Figure 28: Orthobiologics Market, Spain, Revenue ($m), 2009-2016 46

Figure 29: Orthobiologics Market, Brazil, Revenue ($m), 2002-2009 47

Figure 30: Orthobiologics Market, Brazil, Revenue ($m), 2009-2016 48

Figure 31: Orthobiologics Market, Japan, Revenue ($m), 2002-2009 49

Figure 32: Orthobiologics Market, Japan, Revenue ($m), 2009-2016 50

Figure 33: Orthobiologics Market, China, Revenue ($m), 2002-2009 51

Figure 34: Orthobiologics Market, China, Revenue ($m), 2009-2016 52

Figure 35: Orthobiologics Market, India, Revenue ($m), 2002-2009 53

Figure 36: Orthobiologics Market, India, Revenue ($m), 2009-2016 54

Figure 37: Orthobiologics Market, Australia, Revenue ($m), 2002-2009 55

Figure 38: Orthobiologics Market, Australia, Revenue ($m), 2009-2016 56

Figure 39: Medtronic, Inc. , Pipeline Products, 2010 57

Figure 40: Depuy, Pipeline Products, 2010 59

Figure 41: Smith & Nephew , Pipeline Products, 2010 60

Figure 42: Stryker , Pipeline Products, 2010 61

Figure 43: Orthofix International , Pipeline Products, 2010 62

Figure 44: Pipeline Products, Orthobiologics, by Development Stage, Global, 2010 63

Figure 45: Pipeline Products, Orthobiologics, by Segment, Global, 2010 64

Figure 46: Orthobiologics Market Deal Analysis, Value ($m) and Volume, 2006–2010 75

To order this report:

Error! Hyperlink reference not valid.: Orthobiologics to 2016 - Alternatives to Surgery and Superior Outcomes are Driving Wider Adoption of Orthobiologics

Error! Hyperlink reference not valid.

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker



RELATED LINKS

http://www.reportlinker.com